Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Snai3 | Rat | 17beta-estradiol | multiple interactions | ISO | SNAI3 (Homo sapiens) | 6480464 | [Arsenic co-treated with Estradiol] results in increased expression of SNAI3 mRNA; [Estradiol co-treated with TGFB1 more ... | CTD | PMID:30165855|PMID:33047385 | Snai3 | Rat | 17beta-estradiol | decreases expression | ISO | Snai3 (Mus musculus) | 6480464 | Estradiol results in decreased expression of SNAI3 mRNA | CTD | PMID:39298647 | Snai3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Snai3 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SNAI3 mRNA | CTD | PMID:21570461|PMID:24058054 | Snai3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SNAI3 mRNA | CTD | PMID:32109520 | Snai3 | Rat | 3-Nitrobenzanthrone | increases expression | ISO | SNAI3 (Homo sapiens) | 6480464 | 3-nitrobenzanthrone results in increased expression of SNAI3 mRNA | CTD | PMID:34036453 | Snai3 | Rat | 4,4'-diaminodiphenylmethane | decreases expression | ISO | Snai3 (Mus musculus) | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of SNAI3 mRNA | CTD | PMID:18648102 | Snai3 | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | Snai3 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of SNAI3 mRNA | CTD | PMID:39298647 | Snai3 | Rat | 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid | increases expression | ISO | SNAI3 (Homo sapiens) | 6480464 | Am 580 results in increased expression of SNAI3 mRNA | CTD | PMID:16982809 | Snai3 | Rat | acetamide | decreases expression | EXP | | 6480464 | acetamide results in decreased expression of SNAI3 mRNA | CTD | PMID:31881176 | Snai3 | Rat | actinomycin D | multiple interactions | ISO | SNAI3 (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased expression of SNAI3 mRNA | CTD | PMID:38460933 | Snai3 | Rat | aflatoxin B1 | increases expression | ISO | SNAI3 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of SNAI3 mRNA | CTD | PMID:21641981 | Snai3 | Rat | aldehydo-D-glucose | multiple interactions | ISO | Snai3 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] more ... | CTD | PMID:37567420 | Snai3 | Rat | arsane | increases methylation | ISO | SNAI3 (Homo sapiens) | 6480464 | Arsenic results in increased methylation of SNAI3 promoter | CTD | PMID:21291286 | Snai3 | Rat | arsane | multiple interactions | ISO | SNAI3 (Homo sapiens) | 6480464 | [Arsenic co-treated with Estradiol] results in increased expression of SNAI3 mRNA | CTD | PMID:33047385 | Snai3 | Rat | arsenic atom | increases methylation | ISO | SNAI3 (Homo sapiens) | 6480464 | Arsenic results in increased methylation of SNAI3 promoter | CTD | PMID:21291286 | Snai3 | Rat | arsenic atom | multiple interactions | ISO | SNAI3 (Homo sapiens) | 6480464 | [Arsenic co-treated with Estradiol] results in increased expression of SNAI3 mRNA | CTD | PMID:33047385 | Snai3 | Rat | benzo[a]pyrene | affects methylation | ISO | SNAI3 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of SNAI3 promoter | CTD | PMID:27901495 | Snai3 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SNAI3 mRNA | CTD | PMID:25181051 | Snai3 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SNAI3 mRNA | CTD | PMID:29323181 | Snai3 | Rat | bisphenol A | affects methylation | ISO | Snai3 (Mus musculus) | 6480464 | bisphenol A affects the methylation of SNAI3 promoter | CTD | PMID:27334623 | Snai3 | Rat | butanal | increases expression | ISO | SNAI3 (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of SNAI3 mRNA | CTD | PMID:26079696 | Snai3 | Rat | cadmium atom | increases expression | ISO | SNAI3 (Homo sapiens) | 6480464 | Cadmium results in increased expression of SNAI3 mRNA | CTD | PMID:24376830 | Snai3 | Rat | calcitriol | increases expression | ISO | SNAI3 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of SNAI3 mRNA | CTD | PMID:21592394 | Snai3 | Rat | calcitriol | multiple interactions | ISO | SNAI3 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of SNAI3 mRNA | CTD | PMID:21592394 | Snai3 | Rat | camptothecin | increases expression | ISO | SNAI3 (Homo sapiens) | 6480464 | Camptothecin results in increased expression of SNAI3 mRNA | CTD | PMID:38460933 | Snai3 | Rat | cisplatin | increases expression | ISO | SNAI3 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of SNAI3 mRNA | CTD | PMID:27392435 | Snai3 | Rat | cisplatin | multiple interactions | ISO | SNAI3 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of SNAI3 mRNA | CTD | PMID:27392435 | Snai3 | Rat | cocaine | increases expression | EXP | | 6480464 | Cocaine results in increased expression of SNAI3 mRNA | CTD | PMID:27899881 | Snai3 | Rat | copper atom | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of SNAI3 mRNA | CTD | PMID:26033743 | Snai3 | Rat | copper(0) | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of SNAI3 mRNA | CTD | PMID:26033743 | Snai3 | Rat | D-glucose | multiple interactions | ISO | Snai3 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] more ... | CTD | PMID:37567420 | Snai3 | Rat | Dibutyl phosphate | affects expression | ISO | SNAI3 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of SNAI3 mRNA | CTD | PMID:37042841 | Snai3 | Rat | doxorubicin | decreases expression | ISO | Snai3 (Mus musculus) | 6480464 | Doxorubicin results in decreased expression of SNAI3 mRNA | CTD | PMID:39631538 | Snai3 | Rat | entinostat | increases expression | ISO | SNAI3 (Homo sapiens) | 6480464 | entinostat results in increased expression of SNAI3 mRNA | CTD | PMID:32870474 | Snai3 | Rat | fructose | multiple interactions | ISO | Snai3 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] more ... | CTD | PMID:37567420 | Snai3 | Rat | glucose | multiple interactions | ISO | Snai3 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] more ... | CTD | PMID:37567420 | Snai3 | Rat | hydralazine | multiple interactions | ISO | SNAI3 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of SNAI3 mRNA | CTD | PMID:17183730 | Snai3 | Rat | lipopolysaccharide | decreases expression | ISO | SNAI3 (Homo sapiens) | 6480464 | Lipopolysaccharides results in decreased expression of SNAI3 mRNA | CTD | PMID:35811015 | Snai3 | Rat | lipopolysaccharide | multiple interactions | ISO | SNAI3 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SNAI3 mRNA; [S-(1,2-dichlorovinyl)cysteine more ... | CTD | PMID:35811015 | Snai3 | Rat | N-methyl-4-phenylpyridinium | decreases expression | ISO | SNAI3 (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of SNAI3 mRNA | CTD | PMID:32870474 | Snai3 | Rat | Nutlin-3 | multiple interactions | ISO | SNAI3 (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased expression of SNAI3 mRNA | CTD | PMID:38460933 | Snai3 | Rat | oxidopamine | increases expression | ISO | SNAI3 (Homo sapiens) | 6480464 | Oxidopamine results in increased expression of SNAI3 mRNA | CTD | PMID:32870474 | Snai3 | Rat | potassium dichromate | decreases expression | ISO | Snai3 (Mus musculus) | 6480464 | Potassium Dichromate results in decreased expression of SNAI3 mRNA | CTD | PMID:23608068 | Snai3 | Rat | propanal | increases expression | ISO | SNAI3 (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of SNAI3 mRNA | CTD | PMID:26079696 | Snai3 | Rat | rotenone | decreases expression | ISO | SNAI3 (Homo sapiens) | 6480464 | Rotenone results in decreased expression of SNAI3 mRNA | CTD | PMID:32870474 | Snai3 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | SNAI3 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SNAI3 mRNA; [S-(1,2-dichlorovinyl)cysteine more ... | CTD | PMID:35811015 | Snai3 | Rat | silicon dioxide | increases expression | ISO | SNAI3 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of SNAI3 mRNA | CTD | PMID:25895662 | Snai3 | Rat | silicon dioxide | increases expression | ISO | Snai3 (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of SNAI3 mRNA | CTD | PMID:29341224 | Snai3 | Rat | sodium arsenite | decreases expression | ISO | Snai3 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of SNAI3 mRNA | CTD | PMID:37682722 | Snai3 | Rat | sotorasib | multiple interactions | ISO | SNAI3 (Homo sapiens) | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SNAI3 mRNA | CTD | PMID:36139627 | Snai3 | Rat | tamoxifen | decreases expression | ISO | Snai3 (Mus musculus) | 6480464 | Tamoxifen results in decreased expression of SNAI3 mRNA | CTD | PMID:25123088 | Snai3 | Rat | testosterone | multiple interactions | ISO | SNAI3 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of SNAI3 mRNA | CTD | PMID:21592394 | Snai3 | Rat | testosterone | increases expression | ISO | SNAI3 (Homo sapiens) | 6480464 | Testosterone results in increased expression of SNAI3 mRNA | CTD | PMID:21592394 | Snai3 | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of SNAI3 mRNA | CTD | PMID:31150632 | Snai3 | Rat | trametinib | multiple interactions | ISO | SNAI3 (Homo sapiens) | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SNAI3 mRNA | CTD | PMID:36139627 | Snai3 | Rat | triphenyl phosphate | affects expression | ISO | SNAI3 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of SNAI3 mRNA | CTD | PMID:37042841 | Snai3 | Rat | triptonide | increases expression | ISO | Snai3 (Mus musculus) | 6480464 | triptonide results in increased expression of SNAI3 mRNA | CTD | PMID:33045310 | Snai3 | Rat | valproic acid | increases methylation | ISO | SNAI3 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of SNAI3 gene | CTD | PMID:29154799 | Snai3 | Rat | valproic acid | multiple interactions | ISO | SNAI3 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of SNAI3 mRNA | CTD | PMID:17183730 | Snai3 | Rat | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of SNAI3 mRNA | CTD | PMID:23869203 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





















